(2 years, 5 months ago)
Commons ChamberI am pleased to say that we have more nurses working for the NHS than at any point in its history, and last year we recruited an additional 10,900.
Does my right hon. Friend the Secretary of State accept that some people have died as a direct result of having had covid-19 vaccines?
(2 years, 11 months ago)
Commons ChamberI am very sorry to hear about the hon. Gentleman’s constituent. Of course there will be many people across the country who found themselves in such an awful situation. In terms of what he refers to about what may or may not have happened in Downing Street, I believe that my right hon. Friend the Prime Minister addressed that from the Dispatch Box earlier today.
It is often said that the first casualty of war is the truth. Does my right hon. Friend accept that in the so-called war against covid-19, truth is indeed the casualty? In his statement he used expressions such as “could”, “can”, “potential”, “suggests” and “might”. Does that not show that there is no justification for these restrictions upon liberty?
My hon. Friend will know that when it comes to, in this case, a new variant, or viruses more generally that are new in some way, there are uncertainties —there always will be. I do not think a new infection is going to come along and we will have all the answers to all the questions we would logically have on day one. But I hope he agrees in terms of what we do know. For example, I said in my statement that we are confident about the transmissibility—the growth rate—of this, and I hope he will respect that.
(2 years, 11 months ago)
Commons ChamberI am not aware of the details of the individual cases that the hon. Gentleman mentions, but a variety of credit cards and payment systems can be used. If he believes there has been a failure of the system, I would be happy to take a closer look at that.
Can my right hon. Friend tell the House what he is doing to promote the availability of the vaccine damage payment scheme, and does he recognise that that could be a good counter against vaccine hesitancy? When, however, will the scheme be made fit for purpose?
We are reviewing that scheme, for reasons that my hon. Friend has brought up in the past in the House. I agree that it is important to have confidence in vaccines, and that scheme has a role to play.
(3 years ago)
Commons ChamberI want to ensure that all the support that is needed for our vaccination programme is there, across England. The hon. Lady rightly asked what we were doing to reach out to those who, for whatever reason, have so far been a bit hesitant. We have been working actively for months with many community leaders. We have added many more venues and ways in which to receive the vaccine, so access has been improved. Significant work is also being done on communications and ensuring that the right messages are there, and that people, including clinicians, are available to answer questions. However, the hon. Lady was right to point to the importance of this issue, and I am pleased to hear that she will be getting boosted this weekend.
Ivermectin has shown promising results as a potential treatment for covid-19 in places including South Africa. More than five months ago it was added to the Oxford University trial, which is called PRINCIPLE. When will the results of that trial be available, and what are the Government doing to expedite the process? Ivermectin may not be a magic bullet, but on the other hand, it may be.
My hon. Friend has made an important point. One reason for the difference between dealing with this pandemic today and dealing with it even a year ago is that we already have more treatments, and my hon. Friend has just mentioned another potential new treatment. I am afraid that I cannot give him any exact date for when we think the trials will be over, but I am pleased that they are taking place. He is right to point to the potential of that treatment, but I can reassure him that whether the UK’s engagement is with ivermectin or with other potential new treatments, it could not be more engaged.
(3 years, 4 months ago)
Commons ChamberThe Government are speaking with one voice, and I believe our view is very clear.
Tomorrow, my right hon. Friend will be asking the House to approve regulations that will put thousands of care workers in England out of a job. Two weeks ago, we were promised that a regulatory impact assessment was available. As of midday today, it is still not available. When will it be available, and why has it not been made available so far?
The guidance that we will publish today will be very clear on that.
On a point of order, Madam Deputy Speaker. It arises directly out of the response that the Secretary of State gave to me. Tomorrow this House is being asked to approve the Draft Health and Social Care Act 2008 (Regulated Activities) (Amendment) (Coronavirus) Regulations 2021. When that instrument was laid on 22 June, the explanatory memorandum said:
“A full impact assessment of the costs and benefits of this instrument is”—
I emphasise “is”—
“available from the Department of Health and Social Care…and is published alongside this instrument”.
As of 12 o’clock today, I have been trying, through the good offices of our excellent colleagues in the Library, to get an answer from the Department as to when we are going to get that impact assessment. The officials at the DHSC are quoted by the Library as having said, “The impact assessment has not been laid yet”—we knew that—and, “We will be laying it at the earliest opportunity.” This is very serious, because on 6 July the Secondary Legislation Scrutiny Committee referred to the impossibility of being able to scrutinise the legislation properly without the impact assessment. Despite the Secondary Legislation Scrutiny Committee recommending that the debate be deferred, nothing has happened and all that the Secretary of State said in response to me was, “Well, we don’t know where it is but don’t worry about it—we’ll carry on tomorrow anyway.” That is just not good enough. I would be grateful for your guidance, Madam Deputy Speaker, as to what we can do to ensure that we have an informed debate with the impact assessment before us.